엘라코르® 마이크로 코링 기술® Fitzpatrick 피부 유형 I-VI, 글루카곤 유사 펩타이드-1 수용체 자극제를 복용하는 환자 포함
NCT: NCT07224880 · COMPLETED
광고
간략 요약
The main purpose of the study is to collect information about how the device functions in a variety of treatment areas and skin types and to find out what changes, if any, occur in the skin treated with the study device compared to the skin that wasn't treated including patients receiving GLP-1's, a class of medications that mimic a natural hormone to help control blood sugar and support weight loss. The study will also evaluate side effects that occur with this treatment, if any. Standardized 2D Imaging will be used to quantify reduction of wrinkle severity
공식 출처
ClinicalTrials.gov에서 보기 →데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.